1) Bessesen MT, Shlay JT, Stone-Venohr B, Cohn DL, Reves RR. Disseminated Mycobacterium genavense infection in AIDS: Clinical and microbiological features and response to therapy. AIDS, 7:1357-61, 1993
2) Pechere M, Opravil M, Wald A, Chave JP, Bessesen M, Sievers A, Hein R, von Overbeck J, Clark RA, Tortoli E, Emler S, Kirschner P, Gabriel V, Bottger E, Hirschel B, the Swiss HIV Cohort Study. Clinical and epidemiologic features of infection with Mycobacterium genavense. Arch Intern Med, 155:400-404, 1995.
3) Bessesen MT, Miller LA, Cohn DL, Bartlett S, Ellison RT. Pharmacokinetics and toxicity of fansidar in the prophylaxis of Pneumocystis carinii pneumonia in AIDS. Clinical Infectious Diseases, 20:730-1, 1995
4) Bessesen M, Ives D, Condreay L, Lawrence S, Sherman KE. Chronic active hepatitis B exacerbations in HIV-infected patients following development of resistance to or withdrawal of lamivudine. Clinical Infectious Diseases, 28:1032-5, 1999
5) Koeppe J., Belknap R., Bessesen M. Mycobacterium avium complex peritonitis in the setting of cirrhosis. Scandinavian Journal of Infectious Disease, 36:615-7, 2004
6) Wyles D, Weinberg, A, Bessesen M, Madinger N, Schooley R. Development of Herpes Simplex Virus Disease in Patients Receiving Cidofovir, Clin Infect Diseases, 41:676-80 2005, Epub 2005 Jul 26
7) Bessesen MT. Toxic Shock Syndrome In Critical Care Secrets, ed PE Parsons, JP Weiner-Kronish. Hanley & Belfus, Philadelphia, 1998
8) Bessesen MT. Life-Threatening Community-Acquired Infections: Toxic Shock Syndrome, Overwhelming Postsplenectomy Infection, Meningococcemia, Malaria, Rocky Mountain Spotted Fever, and Others; In Irwin & Rippe's Intensive Care Medicine. Lippincott Williams & Wilkins, York, Pennsylvania, 2006